Literature DB >> 8838152

Functional significance of myocellular hypertrophy in dilated cardiomyopathy: histomorphometric analysis on 40 endomyocardial biopsies.

P Gallo1, G d'Amati, F Pelliccia, P Bernucci, C Cianfrocca, B Marino.   

Abstract

Dilated cardiomyopathy is characterized by an increase in myocardial mass. In order to study the functional significance of myocellular hypertrophy in dilated cardiomyopathy, 40 left ventricular endomyocardial biopsies were investigated, by comparing morphometrical data with functional indexes. The extent of myofibril volume fraction was directly associated with a better functional condition, as measured by ejection fraction (p < 0.01) and cardiac index (p < 0.05). Patients with oversize nuclei (nuclear area being > or = 70 microns 2) had a worse functional status (p < 0.05), as determined by ejection fraction and cardiac index. Finally, the extent of interstitial fibrosis was directly correlated to mean right atrial pressure (p < 0.01), right ventricular end-diastolic pressure (p < 0.02) and mean pulmonary artery pressure (p < 0.02). In conclusion, a worse functional status correlates with a reduced myofibril volume fraction and an oversize nuclear area, as in hypertrophic cells undergoing regressive changes.

Entities:  

Mesh:

Year:  1995        PMID: 8838152

Source DB:  PubMed          Journal:  Am J Cardiovasc Pathol        ISSN: 0887-8005


  3 in total

1.  Changes in myocardial cytoskeletal intermediate filaments and myocyte contractile dysfunction in dilated cardiomyopathy: an in vivo study in humans.

Authors:  S Di Somma; M Marotta; G Salvatore; G Cudemo; G Cuda; F De Vivo; M P Di Benedetto; F Ciaramella; G Caputo; O de Divitiis
Journal:  Heart       Date:  2000-12       Impact factor: 5.994

2.  Myofibril degeneration caused by tropomodulin overexpression leads to dilated cardiomyopathy in juvenile mice.

Authors:  M A Sussman; S Welch; N Cambon; R Klevitsky; T E Hewett; R Price; S A Witt; T R Kimball
Journal:  J Clin Invest       Date:  1998-01-01       Impact factor: 14.808

3.  Ablation of cyclase-associated protein 2 (CAP2) leads to cardiomyopathy.

Authors:  Vivek S Peche; Tad A Holak; Bhagyashri D Burgute; Kosmas Kosmas; Sushant P Kale; F Thomas Wunderlich; Fatiha Elhamine; Robert Stehle; Gabriele Pfitzer; Klaus Nohroudi; Klaus Addicks; Florian Stöckigt; Jan W Schrickel; Julia Gallinger; Michael Schleicher; Angelika A Noegel
Journal:  Cell Mol Life Sci       Date:  2012-09-04       Impact factor: 9.261

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.